Cargando...
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
Hematological malignancies are important diseases that need more powerful therapeutics. Even with current targeting therapies, such as rituximab and other chemotherapeutic agents, there is a need to develop new treatment strategies. Combination therapy seems the best option to target the tumor cells...
Guardado en:
| Publicado en: | Oncolytic Virother |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4996254/ https://ncbi.nlm.nih.gov/pubmed/27579294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S95250 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|